Literature DB >> 24683206

Prevalence of Helicobacter pylori in symptomatic patients and detection of clarithromycin resistance using melting curve analysis.

Ayse Demet Kaya1, C Elif Oztürk1, Yusuf Akcan2, Mustafa Behçet1, A Esra Karakoç3, Mihriban Yücel3, Müge Mısırlıoglu4, Serdar Tuncer4.   

Abstract

UNLABELLED: Abstract.
BACKGROUND: Clarithromycin is often a component of combination therapies for Helicobacter pylori eradication; however, increases in resistance rates have decreased the success of the treatment.
OBJECTIVE: This study was designed to determine the prevalence of H pylori infection in symptomatic patients and to detect clarithromycin resistance rates using melting curve analysis.
METHODS: Patients scheduled for upper endoscopy at the Endoscopy Unit of the Department of Gastroenterology, Duzce University, Medical Faculty Hospital, Konuralp/Duzce, Turkey, were assessed for enrollment in the study. Two pairs of gastric biopsy specimens (antrum and corpus) were obtained from each study patient. Histopathologic examination, rapid urease test, culture, and polymerase chain reaction (PCR) of the specimens were used to identify H pylori infection. Clarithromycin resistance was detected using melting curve analysis.
RESULTS: Seventy-five patients (41 women, 34 men; mean [SD]age, 42.6 [14.5] years [range, 17-70 years]) were included in the study. Using histopathology and rapid urease test, H pylori was detected in 40 (53.3%) of the 75 specimens. H pylori was detected using PCR in 40 (53.3%) specimens and by culture in 10 (13.3%) specimens. The specificity and sensitivity of PCR and culture were interpreted by comparing them with the results of histopathologic examination and urease tests. The specificity and sensitivity of PCR were 68.6% and 72.5%, respectively, and the specificity and sensitivity of culture were 97.1% and 22.5%, respectively. Of the 40 isolates, 21 (52.5%) were susceptible to clarithromycin, 12 (30.0%) were resistant, and a mixed susceptibility pattern was detected in 7 (17.5%) specimens. H pylori isolates from 19 (79.2%) of the 24 patients who had formerly used clarithromycin showed clarithromycin resistance.
CONCLUSIONS: The prevalence of H pylori infection was 53.3% for the symptomatic patients in this study, and 47.5% of the isolates showed clarithromycin resistance using melting curve analysis. The PCR-based system used in this study was accurate for the detection of H pylori infection as well as clarithromycin susceptibility testing directly in biopsy specimens.

Entities:  

Keywords:  Helicobacter pylori; PCR; clarithromycin resistance; melting curve analysis

Year:  2007        PMID: 24683206      PMCID: PMC3967324          DOI: 10.1016/j.curtheres.2007.06.001

Source DB:  PubMed          Journal:  Curr Ther Res Clin Exp        ISSN: 0011-393X


  26 in total

Review 1.  H pylori antibiotic resistance: prevalence, importance, and advances in testing.

Authors:  F Mégraud
Journal:  Gut       Date:  2004-09       Impact factor: 23.059

2.  Comparison of invasive methods and two different stool antigen tests for diagnosis of H pylori infection in patients with gastric bleeding.

Authors:  Ebru Demiray; Ozlem Yilmaz; Cihat Sarkis; Mujde Soyturk; Ilkay Simsek
Journal:  World J Gastroenterol       Date:  2006-07-14       Impact factor: 5.742

3.  Polymerase chain reaction: a sensitive method for detecting Helicobacter pylori infection in bleeding peptic ulcers.

Authors:  Ching-Chu Lo; Kwok-Hung Lai; Nan-Jing Peng; Gin-Ho Lo; Hui-Hwa Tseng; Chiun-Ku Lin; Chang-Bih Shie; Chao-Ming Wu; Yu-Shan Chen; Wen-Keui Huang; Angela Chen; Ping-I Hsu
Journal:  World J Gastroenterol       Date:  2005-07-07       Impact factor: 5.742

4.  Rapid detection of clarithromycin resistance in Helicobacter pylori using a PCR-based denaturing HPLC assay.

Authors:  Patrizia Posteraro; Giovanna Branca; Maurizio Sanguinetti; Stefania Ranno; Giovanni Cammarota; Siavash Rahimi; Mario De Carlo; Brunella Posteraro; Giovanni Fadda
Journal:  J Antimicrob Chemother       Date:  2005-11-11       Impact factor: 5.790

5.  European multicentre survey of in vitro antimicrobial resistance in Helicobacter pylori.

Authors:  Y Glupczynski; F Mégraud; M Lopez-Brea; L P Andersen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2001-11       Impact factor: 3.267

6.  Distribution of antibiotic MICs for Helicobacter pylori strains over a 16-year period in patients from Seoul, South Korea.

Authors:  Jung Mogg Kim; Joo Sung Kim; Hyun Chae Jung; Nayoung Kim; Young-Jeon Kim; In Sung Song
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

7.  Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori.

Authors:  J Versalovic; D Shortridge; K Kibler; M V Griffy; J Beyer; R K Flamm; S K Tanaka; D Y Graham; M F Go
Journal:  Antimicrob Agents Chemother       Date:  1996-02       Impact factor: 5.191

8.  Tight binding of clarithromycin, its 14-(R)-hydroxy metabolite, and erythromycin to Helicobacter pylori ribosomes.

Authors:  R C Goldman; D Zakula; R Flamm; J Beyer; J Capobianco
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191

9.  Real-time PCR assay for rapid and accurate detection of point mutations conferring resistance to clarithromycin in Helicobacter pylori.

Authors:  Monica Oleastro; Armelle Ménard; Adriana Santos; Hervé Lamouliatte; Lurdes Monteiro; Philippe Barthélémy; Francis Mégraud
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

10.  Validation of string test for diagnosis of Helicobacter pylori infections.

Authors:  Billie Velapatiño; Jacqueline Balqui; Robert H Gilman; Alejandro Bussalleu; Willi Quino; S Alison Finger; Livia Santivañez; Phabiola Herrera; Alejandro Piscoya; Jose Valdivia; Jaime Cok; Douglas E Berg
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

View more
  4 in total

Review 1.  Pharmacological therapy used in the elimination of Helicobacter pylori infection: a review.

Authors:  Ariolana A Dos Santos; Adriana A Carvalho
Journal:  World J Gastroenterol       Date:  2015-01-07       Impact factor: 5.742

2.  Detection of primary clarithromycin resistance of Helicobacter pylori and association between cagA (+) status and clinical outcome.

Authors:  Erkan Yula; Toğrul Nagiyev; Ozlem Aycan Kaya; Melek Inci; M Murat Celik; Fatih Köksal
Journal:  Folia Microbiol (Praha)       Date:  2012-09-06       Impact factor: 2.099

3.  Evaluation of Invasive and Noninvasive Methods for the Diagnosis of Helicobacter Pylori Infection

Authors:  Yasemin Cosgun; Abdullah Yildirim; Mihriban Yucel; Ayse Esra Karakoc; Gokhan Koca; Alpaslan Gonultas; Gul Gursoy; Huseyin Ustun; Meliha Korkmaz
Journal:  Asian Pac J Cancer Prev       Date:  2016-12-01

4.  Comparison between different first-line therapy protocols in eradicating Helicobacter pylori in a region with high clarithromycin resistance.

Authors:  Baris Yilmaz; Huseyin Koseoglu; Yusuf Coskun; Murat Deveci; Murat Kekilli
Journal:  Prz Gastroenterol       Date:  2018-01-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.